Renewed Support for Lung Cancer Research

The Cancer Research Society (CRS) announces the launch of the second edition of its Lung Cancer Research Grants Competition, backed by a total investment of $2 million. Building on the success of its inaugural competition, this initiative aims to accelerate scientific progress in an area where significant needs remain.

From Paperwork to Patient Care: A Statement in Support of Bill C-265 [An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)]

This special statement has been prepared to support proposed changes to the Act’s Special Access Program section. These changes could give people experiencing serious or life-threatening conditions faster access to medications that aren’t yet approved by Health Canada. Some of these medications could help people living with lung conditions.